-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $700

Benzinga·11/03/2026 16:02:13
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $627 to $700.